Literature DB >> 11305477

Case-control study of risk factors for the development of enterococcal bacteremia.

F J Caballero-Granado1, B Becerril, J M Cisneros, L Cuberos, I Moreno, J Pachón.   

Abstract

To determine the risk factors involved in the development of enterococcal bacteremia, a prospective, observational, case-control study was carried out over 18 months. All episodes of enterococcal bacteremia with clinical significance detected in adults were included. A control matched by sex, age and hospitalization ward (medical, surgical or intensive care unit) was selected randomly for each patient with enterococcal bacteremia. Uni- and multivariate analyses of the epidemiological characteristics of both groups were performed. Etiologic fractions of every risk factor were also determined. One hundred twenty-two pairs were included. The severity of the chronic underlying diseases was similar in both groups. Neutropenia, cirrhosis, organ transplantation, intravascular catheter, urinary catheter, nasogastric tube, parenteral nutrition and previous administration of cephalosporins and imipenem were the factors associated with enterococcal bacteremia in the univariate analysis. The factors independently associated with enterococcal bacteremia in the multivariate analysis were neutropenia (odds ratio [OR] = 8), urinary catheter (OR = 3) and previous administration of cephalosporins (OR = 4) and imipenem (OR = 10). Their respective etiologic fractions were 9%, 44%, 11% and 29%. Efforts to reduce the occurrence of enterococcal bacteremia should be focused on appropriate use of cephalosporins, imipenem and external devices.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305477     DOI: 10.1007/s100960000429

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.

Authors:  Habip Gedik; Funda Şimşek; Arzu Kantürk; Taner Yıldırmak; Deniz Arıca; Demet Aydın; Osman Yokuş; Naciye Demirel
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Intravenous mouse infection model for studying the pathology of Enterococcus faecalis infections.

Authors:  Claudia Gentry-Weeks; Monica Estay; Cindy Loui; Dale Baker
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  The acute-phase response impairs host defence against Enterococcus faecium peritonitis.

Authors:  Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Petra S van den Pangaart; Marc J M Bonten; Tom van der Poll
Journal:  Immunology       Date:  2008-10-30       Impact factor: 7.397

4.  Cecal ligation and puncture induced sepsis impairs host defense against Enterococcus faecium peritonitis.

Authors:  Masja Leendertse; Rob J Willems; Ida A Giebelen; Sandrine Florquin; Petra S van den Pangaart; Marc J Bonten; Tom van der Poll
Journal:  Intensive Care Med       Date:  2009-02-17       Impact factor: 17.440

5.  Neutrophils are essential for rapid clearance of Enterococcus faecium in mice.

Authors:  Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Joris J T H Roelofs; Marc J M Bonten; Tom van der Poll
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

Review 6.  Model systems for the study of Enterococcal colonization and infection.

Authors:  H M Sharon Goh; M H Adeline Yong; Kelvin Kian Long Chong; Kimberly A Kline
Journal:  Virulence       Date:  2017-05-04       Impact factor: 5.882

7.  Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland -commensals or hospital-adapted pathogens?

Authors:  Beata Krawczyk; Magdalena Wysocka; Roman Kotłowski; Marek Bronk; Michał Michalik; Alfred Samet
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

8.  Intestinal colonization with Enterococcus faecium does not influence pulmonary defense against Pseudomonas aeruginosa in mice.

Authors:  Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Joris J T H Roelofs; Janetta Top; Marc J M Bonten; Tom van der Poll
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

9.  Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.

Authors:  Agnes Loo Yee Cheah; Trisha Peel; Benjamin P Howden; Denis Spelman; M Lindsay Grayson; Roger L Nation; David C M Kong
Journal:  BMC Infect Dis       Date:  2014-06-28       Impact factor: 3.090

10.  Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections.

Authors:  Rachael A Lee; Daniel T Vo; Joanna C Zurko; Russell L Griffin; J Martin Rodriguez; Bernard C Camins
Journal:  Open Forum Infect Dis       Date:  2020-02-19       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.